The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

FacebookTweetLinkedInPrint There were big celebrations at an east Donegal hardware store today when one of its most loyal staff ...

Nvidia Corporation's FY25 revenue surged 114% YoY, driven by AI dominance and Blackwell architecture. Click for my updated ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Thatta Cement Company Limited (PSX: THCCL) was incorporated in Pakistan as a public limited company in 1980. The company is ...

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma ...

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a ...

Expect Topline Phase 2 data for NDV-01 for high-grade non-muscle invasive bladder cancer (HG-NMIBC), to be presented at AUA 2025 in ...

Coming into 2025, our key priority will be to accelerate the overall topline growth of our business units given the expected ...

KSE-100 index companies posted earnings of Rs. 1.62 trillion in 2024, down 1 percent YoY from Rs. 1.64 trillion in 2023. In ...

Alterity Therapeutics (ASX:ATH, NASDAQ:ATHE) has announced the completion of its last patient visit in the ATH434-202 ...